Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Striatal norepinephrine efflux in l-DOPA-induced dyskinesia.

Ostock CY, Bhide N, Goldenberg AA, George JA, Bishop C.

Neurochem Int. 2018 Mar;114:85-98. doi: 10.1016/j.neuint.2018.01.010. Epub 2018 Feb 6.

PMID:
29371053
2.

The Role of Primary Motor Cortex (M1) Glutamate and GABA Signaling in l-DOPA-Induced Dyskinesia in Parkinsonian Rats.

Lindenbach D, Conti MM, Ostock CY, George JA, Goldenberg AA, Melikhov-Sosin M, Nuss EE, Bishop C.

J Neurosci. 2016 Sep 21;36(38):9873-87. doi: 10.1523/JNEUROSCI.1318-16.2016.

3.

Alterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia.

Lindenbach D, Conti MM, Ostock CY, Dupre KB, Bishop C.

Neuroscience. 2015 Dec 3;310:12-26. doi: 10.1016/j.neuroscience.2015.09.018. Epub 2015 Sep 9.

4.

Modulation of L-DOPA's antiparkinsonian and dyskinetic effects by α2-noradrenergic receptors within the locus coeruleus.

Ostock CY, Hallmark J, Palumbo N, Bhide N, Conti M, George JA, Bishop C.

Neuropharmacology. 2015 Aug;95:215-25. doi: 10.1016/j.neuropharm.2015.03.008. Epub 2015 Mar 25.

5.

Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats.

Lindenbach D, Palumbo N, Ostock CY, Vilceus N, Conti MM, Bishop C.

Br J Pharmacol. 2015 Jan;172(1):119-30. doi: 10.1111/bph.12894. Epub 2014 Nov 24.

6.

Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat.

Ostock CY, Lindenbach D, Goldenberg AA, Kampton E, Bishop C.

Behav Brain Res. 2014 Aug 15;270:75-85. doi: 10.1016/j.bbr.2014.05.009. Epub 2014 May 13.

7.

Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats.

Conti MM, Ostock CY, Lindenbach D, Goldenberg AA, Kampton E, Dell'isola R, Katzman AC, Bishop C.

Neuropharmacology. 2014 Feb;77:1-8. doi: 10.1016/j.neuropharm.2013.09.017. Epub 2013 Sep 22.

8.

Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.

Lindenbach D, Dupre KB, Eskow Jaunarajs KL, Ostock CY, Goldenberg AA, Bishop C.

Brain Res. 2013 Nov 6;1537:327-39. doi: 10.1016/j.brainres.2013.09.020. Epub 2013 Sep 21.

9.

Effects of 5-HT1A receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats.

Dupre KB, Ostock CY, George JA, Eskow Jaunarajs KL, Hueston CM, Bishop C.

ACS Chem Neurosci. 2013 May 15;4(5):747-60. doi: 10.1021/cn300234z. Epub 2013 Apr 1.

10.

Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation.

Ostock CY, Dupre KB, Jaunarajs KL, Walters H, George J, Krolewski D, Walker PD, Bishop C.

Neuropharmacology. 2011 Sep;61(4):753-60. doi: 10.1016/j.neuropharm.2011.05.021. Epub 2011 May 27.

11.

Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat.

Lindenbach D, Ostock CY, Eskow Jaunarajs KL, Dupre KB, Barnum CJ, Bhide N, Bishop C.

J Pharmacol Exp Ther. 2011 Jun;337(3):755-65. doi: 10.1124/jpet.111.179416. Epub 2011 Mar 14.

12.

Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats.

Dupre KB, Ostock CY, Eskow Jaunarajs KL, Button T, Savage LM, Wolf W, Bishop C.

Exp Neurol. 2011 Jun;229(2):288-99. doi: 10.1016/j.expneurol.2011.02.012. Epub 2011 Feb 22.

13.

Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat.

Eskow Jaunarajs KL, Dupre KB, Ostock CY, Button T, Deak T, Bishop C.

Behav Pharmacol. 2010 Oct;21(7):627-37. doi: 10.1097/FBP.0b013e32833e7e80.

Supplemental Content

Loading ...
Support Center